Study on Radioprotective Effects of GANRAlike Medicine
doi: 10.11804/NuclPhysRev.29.01.109
- Received Date: 1900-01-01
- Rev Recd Date: 1900-01-01
- Publish Date: 2012-03-20
-
Key words:
- GANRA like medicine /
- radioprotective /
- animal model
Abstract: After three days of medicine administrated, Kunming mice were exposured to 8 Gy of 100 kVp Xrays. Hemogram, viscere, survival, MDA yields and SOD activity were examined. Results showes that, (1) Survival of medicineadministrated mice were similar to the control group. After irradiation, survival dropped significantly. It took 20 days for the control group to reach to 50% survival, while 9 days for DMSO group 29 days for 1# drug group, and 24 days for 5# drug group. (2) The medicine per se had no obvious impacts on visceral indexes. Liver index and spleen index of the control group and DMSO group were elevated after irradiated, while those of medicineadministrated group did not change much. (3) The groups treated by DMSO and 1# drug had high yield of MDA, but low activity of SOD. Compared with DMSO group, 5# drug had high SOD activity while low MDA level. Irradiation increased MDA level but decreased SOD activity of every group, However, 5# drug still showed higher SOD activity and lower MDA level than DMSO group. (4) The medicine did not show distinctive contributions to variation of hemogram. In summary, our results demonstrated that GANRAlike 1# and 5# medicine had radioprotective effects and their mechanisms might be related to the scavenging ability of free radicals.
Citation: | ZHU Ming-yue, PEI Hai-long, YE Wen-ling, ZHANG Ya-nan, DING Nan, WANG Ju-fang, LI Wen-jian, ZHOU Guang-ming. Study on Radioprotective Effects of GANRAlike Medicine[J]. Nuclear Physics Review, 2012, 29(1): 109-113. doi: 10.11804/NuclPhysRev.29.01.109 |